resveratrol has been researched along with fluorodeoxyglucose f18 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jung, KH; Lee, EJ; Lee, JH; Lee, KH; Moon, SH; Oh, H; Paik, JY; Park, JW; Thien Quach, CH | 1 |
1 other study(ies) available for resveratrol and fluorodeoxyglucose f18
Article | Year |
---|---|
Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
Topics: Animals; Biological Transport; Cell Line, Tumor; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lactic Acid; Mice; Reactive Oxygen Species; Resveratrol; Signal Transduction; Stilbenes | 2013 |